Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Maxcyte Inc (MXCT)

Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics

MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
MaxCyte to Participate in Two Upcoming Investor Conferences

MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
MaxCyte Appoints Cynthia Collins to its Board of Directors

PSTX : 2.67 (-3.26%)
MXCN.LN : 680.000 (unch)
DMTKQ : 0.0001 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
CERT : 9.99 (+0.30%)
MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024

MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer

MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)
MXCT : 3.23 (-5.56%)
Why Shares of MaxCyte Are Plummeting on Thursday

The biotech company reduced full-year guidance and expects so-so third-quarter revenue.

MXCT : 3.23 (-5.56%)
Nasdaq Futures Slip as Bond Yields Rebound, U.S. Jobs Report Looms

December Nasdaq 100 E-Mini futures (NQZ23) are trending down -0.10% this morning after three major U.S. benchmark indices closed higher on Wednesday as the latest batch of U.S. economic data prompted investors...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
MSFT : 415.76 (+0.18%)
AMZN : 201.70 (-0.45%)
META : 554.40 (+0.06%)
PLTR : 61.26 (-6.86%)
PSX : 131.32 (+1.20%)
MRO : 28.99 (+1.40%)
CALM : 93.97 (+3.91%)
PNDOR.C.DX : 1,096.000 (+1.25%)
MXCT : 3.23 (-5.56%)
BB : 2.39 (+0.42%)
MaxCyte, Inc. (MXCT) Q2 2022 Earnings Call Transcript

MXCT earnings call for the period ending June 30, 2022.

MXCT : 3.23 (-5.56%)
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 3.23 (-5.56%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 267.000 (-1.29%)

Barchart Exclusives

Is It Time to Buy This Dividend Stock With Nuclear Energy Upside?
Apart from its prowess in nuclear energy, this energy company is also deploying AI. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar